Onderneming Nile Therapeutics, Inc. Other OTC
Aandelen
US6541451018
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
13/05 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
13/05 | Capricor Therapeutics, Inc. rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024 | CI |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Transformative Cell and Exosome-based Therapeutics
100,0
%
| 3 | 100,0 % | 25 | 100,0 % | +886,81% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 3 | 100,0 % | 25 | 100,0 % | +886,81% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Linda Marbán
CEO | Chief Executive Officer | 60 | 20-11-13 |
Anthony Bergmann
DFI | Director of Finance/CFO | 38 | 20-11-13 |
Kristi Elliott
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-21 |
Karen Krasney
LAW | General Counsel | 71 | 01-01-12 |
General Counsel | 71 | 28-02-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Philip Gotwals
BRD | Director/Board Member | 61 | 21-07-23 |
Earl Collier
BRD | Director/Board Member | 76 | 20-11-13 |
George Dunbar
BRD | Director/Board Member | 77 | 20-11-13 |
David Musket
BRD | Director/Board Member | 66 | 20-11-13 |
Frank Litvack
CHM | Chairman | 68 | 01-01-12 |
Karimah Es Sabar
BRD | Director/Board Member | 66 | 23-07-21 |
Linda Marbán
CEO | Chief Executive Officer | 60 | 20-11-13 |
Paul Auwaerter
BRD | Director/Board Member | 62 | 13-07-23 |
Michael Kelliher
BRD | Director/Board Member | 47 | 01-09-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 31 811 470 | 28 874 629 ( 90,77 %) | 0 | 90,77 % |
Bedrijfsgegevens
Capricor Therapeutics, Inc.
10865 Road to the Cure Suite 150
92121, San Diego
+858 727 1755
http://www.capricor.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,60% | 113 mld. | |
+10,45% | 106 mld. | |
+0,41% | 22,27 mld. | |
-12,12% | 22,22 mld. | |
-5,99% | 19,43 mld. | |
-37,36% | 17,87 mld. | |
-5,10% | 17,24 mld. | |
+6,63% | 14,29 mld. | |
+36,23% | 12,52 mld. |
- Beurs
- Aandelen
- Koers CAPR
- Koers
- Onderneming Nile Therapeutics, Inc.